We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$39.1B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
-0.73%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$21B
AUM Growth
-$562M
(-2.6%)
Cap. Flow
-$305M
Cap. Flow
% of AUM
-1.45%
Top 10 Holdings %
Top 10 Hldgs %
43.23%
Holding
256
New
8
Increased
47
Reduced
126
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$92M |
| 2 |
Gilead Sciences
GILD
|
+$86.1M |
| 3 |
Chubb
CB
|
+$11.5M |
| 4 |
EOG Resources
EOG
|
+$8.76M |
| 5 |
State Street
STT
|
+$7.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$55.5M |
| 2 |
Apple
AAPL
|
+$32.3M |
| 3 |
GE Aerospace
GE
|
+$32.1M |
| 4 |
ExxonMobil
XOM
|
+$31.5M |
| 5 |
Kinder Morgan
KMI
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 27.96% |
| 2 | Energy | 25.29% |
| 3 | Financials | 12.53% |
| 4 | Healthcare | 10.76% |
| 5 | Technology | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Williams Companies
WMB
$85.8B
| $339K | ﹤0.01% |
8,360
-90
| -1% | -$3.65K |
|
|
EPB
202
DELISTED
EL PASO PIPELINE PARTNERS, L.P. COM UNITS REPSTG LTD PART
EPB
| $334K | ﹤0.01% |
11,000
+550
| +5% | +$17.4K |
|
203
Ford
F
$60.9B
| $333K | ﹤0.01% |
21,363
+349
| +2% | +$5.4K |
|
|
FISV
204
Fiserv Inc
FISV
$29.7B
| $326K | ﹤0.01% |
11,500
-740
| -6% | -$21.2K |
|
205
iShares Core S&P Small-Cap ETF
IJR
$109B
| $325K | ﹤0.01% |
5,894
-866
| -13% | -$46.8K |
|
206
Teva Pharmaceuticals
TEVA
$40.4B
| $325K | ﹤0.01% |
6,150
-150
| -2% | -$6.93K |
|
207
Zions Bancorporation
ZION
$10.1B
| $317K | ﹤0.01% |
10,221
-1,540
| -13% | -$46.8K |
|
208
Sherwin-Williams
SHW
$83.5B
| $315K | ﹤0.01% |
4,800
| – | – |
|
|
NGLS
209
DELISTED
TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT
NGLS
| $308K | ﹤0.01% |
5,475
| – | – |
|
210
World Kinect Corp
WKC
$2.06B
| $304K | ﹤0.01% |
6,900
| – | – |
|
211
W.W. Grainger
GWW
$64.2B
| $303K | ﹤0.01% |
+1,201
| New | +$300K |
|
212
Lumen
LUMN
$6.43B
| $300K | ﹤0.01% |
9,130
-230
| -2% | -$7.04K |
|
|
SE
213
DELISTED
Spectra Energy Corp Wi
SE
| $294K | ﹤0.01% |
7,957
+632
| +9% | +$22.9K |
|
214
Ameriprise Financial
AMP
$47.8B
| $289K | ﹤0.01% |
2,624
-184
| -7% | -$20.1K |
|
215
ATI
ATI
$24.3B
| $287K | ﹤0.01% |
7,625
| – | – |
|
216
Illinois Tool Works
ITW
$84.1B
| $287K | ﹤0.01% |
3,525
-100
| -3% | -$8.09K |
|
|
CATM
217
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $286K | ﹤0.01% |
7,358
| – | – |
|
218
Conagra Brands
CAG
$7.42B
| $282K | ﹤0.01% |
11,663
-7,067
| -38% | -$170K |
|
219
Devon Energy
DVN
$51.3B
| $272K | ﹤0.01% |
4,068
+125
| +3% | +$7.76K |
|
220
APA Corp
APA
$13B
| $266K | ﹤0.01% |
3,202
-129
| -4% | -$10.6K |
|
221
Cullen/Frost Bankers
CFR
$10.5B
| $265K | ﹤0.01% |
3,417
| – | – |
|
|
COL
222
DELISTED
Rockwell Collins
COL
| $261K | ﹤0.01% |
3,279
| – | – |
|
223
Alcoa
AA
$11.3B
| $257K | ﹤0.01% |
8,323
| – | – |
|
224
CVS Health
CVS
$135B
| $256K | ﹤0.01% |
3,414
+195
| +6% | +$13.8K |
|
225
Howard Hughes
HHH
$3.94B
| $249K | ﹤0.01% |
1,827
| – | – |
|
Similar funds
HF
Fayez Sarofim & Co's Q1 2014 Portfolio in Review
As of Q1 2014, Fayez Sarofim & Co held 256 positions worth $21B, down 2.6% from $21.5B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Fayez Sarofim & Co's Q1 2014 filing shows 8 new, 47 increased, 126 reduced and 11 closed positions. Its largest new stake was Gilead Sciences: 1,098,306 shares worth $78.4M. The largest sale was Intuitive Surgical, an estimated $55.5M.
By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, down from 29% a quarter earlier, followed by Energy and Financials.
- Fayez Sarofim & Co's largest Q1 2014 buy was Gilead Sciences: 1,098,306 shares worth $78.4M.
- Fayez Sarofim & Co added most to Union Pacific in Q1 2014, an estimated $92M increase.
- Fayez Sarofim & Co's biggest Q1 2014 reduction was Intuitive Surgical, cutting an estimated $55.5M.
- Fayez Sarofim & Co fully exited State Street SPDR S&P 500 ETF Trust in Q1 2014, selling an estimated $3.03M.
- Fayez Sarofim & Co's ten largest holdings make up 43% of its $21B portfolio in Q1 2014.
- Fayez Sarofim & Co opened 8 new positions and closed 11 in Q1 2014.
- Fayez Sarofim & Co's portfolio value fell 2.6% quarter-over-quarter to $21B.
Based on Fayez Sarofim & Co's 13F filing for Q1 2014, filed 14 May 2014.